Efficacy and safety of biological agents in adult-onset Still’s disease

Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan

(2014) Rie Suematsu et al.   Modern Rheumatology

Biologic treatments for adult-onset Still's disease

(2013) I. A. Al-Homood   RHEUMATOLOGY

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

(2012) D. NORDSTROM et al.   JOURNAL OF RHEUMATOLOGY

Anakinra in Adult-Onset Still's Disease: Long-Term Treatment in Patients Resistant to Conventional Therapy

(2012) Cecilia Giampietro et al.   ARTHRITIS CARE & RESEARCH

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study

(2011) Katerina Laskari et al.   ARTHRITIS RESEARCH & THERAPY

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade

(2010) J. Rech et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease

(2010) Stefano Franchini et al.   ARTHRITIS AND RHEUMATISM

Tocilizumab in refractory adult Still's disease

(2010) Xavier Puéchal et al.   ARTHRITIS CARE & RESEARCH